This continued churn between the low 3s and high 3s would appear to be daytraders controlling the stock. I can see no real reason it should continue to drop after high volume buying.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025